Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to ...
Kailera Therapeutics appears to have set a new benchmark for biotech IPOs with an upsized $625 million offering to fund its ...
10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.
The cleaning process used by Freudenberg Medical uses ultrapure water and air, operating within ISO 5 conditions.
After receiving the FDA’s greenlight for Hunter syndrome drug Avlayah, Denali Therapeutics CEO Ryan Watts saw the culmination ...
Panorama France HealthTech 2026 's review: a mature, innovative and resilient sector facing a more demanding environment-- An ecosystem of nearly 2,800 companies, driven by innova ...
Onvida Health has made significant advancements in robotic surgery and is now receiving recognition from a major ...
Samchundang Pharmaceutical has refuted reports that the patent for its drug delivery platform "S-PASS" was filed under the name of Taiwanese company ...
BIO Asia–Taiwan 2026 Chairman Johnsee Lee highlighted three major features of this year's gathering. First, showcasing new ...
2don MSN
$150K over asking isn't enough: NJ real estate agent warns ‘average person’ is being priced out
Soon enough, the average American homebuyer won't be able to afford homes in New Jersey suburbs, as one real estate agent ...
Master ultra-high-throughput screening principles. Learn how advanced automation and miniaturization accelerate drug discovery and laboratory workflows.
Cybin Inc. is upgraded to Buy, driven by recent regulatory and clinical tailwinds that favor its lead candidate, HLP003.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results